CN114316015B - Insect-resistant protein hRI, and encoding gene and application thereof - Google Patents
Insect-resistant protein hRI, and encoding gene and application thereof Download PDFInfo
- Publication number
- CN114316015B CN114316015B CN202111469961.3A CN202111469961A CN114316015B CN 114316015 B CN114316015 B CN 114316015B CN 202111469961 A CN202111469961 A CN 202111469961A CN 114316015 B CN114316015 B CN 114316015B
- Authority
- CN
- China
- Prior art keywords
- insect
- hri
- leu
- sequence
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000238631 Hexapoda Species 0.000 title claims abstract description 63
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 37
- 230000009261 transgenic effect Effects 0.000 claims abstract description 29
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 241000196324 Embryophyta Species 0.000 claims description 39
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 32
- 241000255967 Helicoverpa zea Species 0.000 claims description 25
- 239000012634 fragment Substances 0.000 claims description 14
- 239000013598 vector Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 244000061176 Nicotiana tabacum Species 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 239000013612 plasmid Substances 0.000 claims description 5
- 235000009429 Gossypium barbadense Nutrition 0.000 claims description 2
- 244000299507 Gossypium hirsutum Species 0.000 claims description 2
- 235000018322 upland cotton Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 230000012010 growth Effects 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 6
- 238000011160 research Methods 0.000 abstract description 3
- 241000208125 Nicotiana Species 0.000 description 27
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 18
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 12
- 230000015556 catabolic process Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 4
- 241000208128 Nicotiana glauca Species 0.000 description 4
- 108010083644 Ribonucleases Proteins 0.000 description 4
- 241000607479 Yersinia pestis Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241000589158 Agrobacterium Species 0.000 description 3
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 238000012271 agricultural production Methods 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 230000009465 prokaryotic expression Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 description 2
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000003392 amylase inhibitor Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 108010004073 cysteinylcysteine Proteins 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- SCPRYBYMKVYVND-UHFFFAOYSA-N 2-[[2-[[1-(2-amino-4-methylpentanoyl)pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)CC(N)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(O)=O SCPRYBYMKVYVND-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- UWQJHXKARZWDIJ-ZLUOBGJFSA-N Ala-Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O UWQJHXKARZWDIJ-ZLUOBGJFSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- WRDANSJTFOHBPI-FXQIFTODSA-N Ala-Arg-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N WRDANSJTFOHBPI-FXQIFTODSA-N 0.000 description 1
- DWINFPQUSSHSFS-UVBJJODRSA-N Ala-Arg-Trp Chemical compound N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O DWINFPQUSSHSFS-UVBJJODRSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- LJFNNUBZSZCZFN-WHFBIAKZSA-N Ala-Gly-Cys Chemical compound N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O LJFNNUBZSZCZFN-WHFBIAKZSA-N 0.000 description 1
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 1
- AUFACLFHBAGZEN-ZLUOBGJFSA-N Ala-Ser-Cys Chemical compound N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O AUFACLFHBAGZEN-ZLUOBGJFSA-N 0.000 description 1
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- ZEAYJGRKRUBDOB-GARJFASQSA-N Arg-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ZEAYJGRKRUBDOB-GARJFASQSA-N 0.000 description 1
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 1
- YKZJPIPFKGYHKY-DCAQKATOSA-N Arg-Leu-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKZJPIPFKGYHKY-DCAQKATOSA-N 0.000 description 1
- HUZGPXBILPMCHM-IHRRRGAJSA-N Asn-Arg-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HUZGPXBILPMCHM-IHRRRGAJSA-N 0.000 description 1
- YNSCBOUZTAGIGO-ZLUOBGJFSA-N Asn-Asn-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N)C(=O)N YNSCBOUZTAGIGO-ZLUOBGJFSA-N 0.000 description 1
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 1
- WQSCVMQDZYTFQU-FXQIFTODSA-N Asn-Cys-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WQSCVMQDZYTFQU-FXQIFTODSA-N 0.000 description 1
- ULRPXVNMIIYDDJ-ACZMJKKPSA-N Asn-Glu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N ULRPXVNMIIYDDJ-ACZMJKKPSA-N 0.000 description 1
- ORJQQZIXTOYGGH-SRVKXCTJSA-N Asn-Lys-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ORJQQZIXTOYGGH-SRVKXCTJSA-N 0.000 description 1
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 1
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- QQXOYLWJQUPXJU-WHFBIAKZSA-N Asp-Cys-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O QQXOYLWJQUPXJU-WHFBIAKZSA-N 0.000 description 1
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 1
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 1
- RTXQQDVBACBSCW-CFMVVWHZSA-N Asp-Ile-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RTXQQDVBACBSCW-CFMVVWHZSA-N 0.000 description 1
- AITKTFCQOBRJTG-CIUDSAMLSA-N Asp-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N AITKTFCQOBRJTG-CIUDSAMLSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- HRVQDZOWMLFAOD-BIIVOSGPSA-N Asp-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N)C(=O)O HRVQDZOWMLFAOD-BIIVOSGPSA-N 0.000 description 1
- XWKPSMRPIKKDDU-RCOVLWMOSA-N Asp-Val-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O XWKPSMRPIKKDDU-RCOVLWMOSA-N 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 101001106957 Bos taurus Ribonuclease pancreatic Proteins 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- KEBJBKIASQVRJS-WDSKDSINSA-N Cys-Gln-Gly Chemical compound C(CC(=O)N)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N KEBJBKIASQVRJS-WDSKDSINSA-N 0.000 description 1
- YZKOXEJTLWZOQL-GUBZILKMSA-N Cys-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CS)N YZKOXEJTLWZOQL-GUBZILKMSA-N 0.000 description 1
- BDWIZLQVVWQMTB-XKBZYTNZSA-N Cys-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N)O BDWIZLQVVWQMTB-XKBZYTNZSA-N 0.000 description 1
- GUKYYUFHWYRMEU-WHFBIAKZSA-N Cys-Gly-Asp Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O GUKYYUFHWYRMEU-WHFBIAKZSA-N 0.000 description 1
- UPURLDIGQGTUPJ-ZKWXMUAHSA-N Cys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N UPURLDIGQGTUPJ-ZKWXMUAHSA-N 0.000 description 1
- UXIYYUMGFNSGBK-XPUUQOCRSA-N Cys-Gly-Val Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O UXIYYUMGFNSGBK-XPUUQOCRSA-N 0.000 description 1
- UEHCDNYDBBCQEL-CIUDSAMLSA-N Cys-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N UEHCDNYDBBCQEL-CIUDSAMLSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- MINZLORERLNSPP-ACZMJKKPSA-N Gln-Asn-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N MINZLORERLNSPP-ACZMJKKPSA-N 0.000 description 1
- PCKOTDPDHIBGRW-CIUDSAMLSA-N Gln-Cys-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)N)CN=C(N)N PCKOTDPDHIBGRW-CIUDSAMLSA-N 0.000 description 1
- RRBLZNIIMHSHQF-FXQIFTODSA-N Gln-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N RRBLZNIIMHSHQF-FXQIFTODSA-N 0.000 description 1
- PNENQZWRFMUZOM-DCAQKATOSA-N Gln-Glu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O PNENQZWRFMUZOM-DCAQKATOSA-N 0.000 description 1
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 1
- VLOLPWWCNKWRNB-LOKLDPHHSA-N Gln-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VLOLPWWCNKWRNB-LOKLDPHHSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 1
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- JHSRJMUJOGLIHK-GUBZILKMSA-N Glu-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N JHSRJMUJOGLIHK-GUBZILKMSA-N 0.000 description 1
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 1
- IXKRSKPKSLXIHN-YUMQZZPRSA-N Gly-Cys-Leu Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O IXKRSKPKSLXIHN-YUMQZZPRSA-N 0.000 description 1
- COVXELOAORHTND-LSJOCFKGSA-N Gly-Ile-Val Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O COVXELOAORHTND-LSJOCFKGSA-N 0.000 description 1
- TWTPDFFBLQEBOE-IUCAKERBSA-N Gly-Leu-Gln Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O TWTPDFFBLQEBOE-IUCAKERBSA-N 0.000 description 1
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- GJHWILMUOANXTG-WPRPVWTQSA-N Gly-Val-Arg Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GJHWILMUOANXTG-WPRPVWTQSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241001147381 Helicoverpa armigera Species 0.000 description 1
- MWXBCJKQRQFVOO-DCAQKATOSA-N His-Cys-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CN=CN1)N MWXBCJKQRQFVOO-DCAQKATOSA-N 0.000 description 1
- LVXFNTIIGOQBMD-SRVKXCTJSA-N His-Leu-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O LVXFNTIIGOQBMD-SRVKXCTJSA-N 0.000 description 1
- YEKYGQZUBCRNGH-DCAQKATOSA-N His-Pro-Ser Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)N)C(=O)N[C@@H](CO)C(=O)O YEKYGQZUBCRNGH-DCAQKATOSA-N 0.000 description 1
- PZAJPILZRFPYJJ-SRVKXCTJSA-N His-Ser-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O PZAJPILZRFPYJJ-SRVKXCTJSA-N 0.000 description 1
- 101001095807 Homo sapiens Ribonuclease inhibitor Proteins 0.000 description 1
- OONBGFHNQVSUBF-KBIXCLLPSA-N Ile-Gln-Cys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(O)=O OONBGFHNQVSUBF-KBIXCLLPSA-N 0.000 description 1
- LKACSKJPTFSBHR-MNXVOIDGSA-N Ile-Gln-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N LKACSKJPTFSBHR-MNXVOIDGSA-N 0.000 description 1
- RWHRUZORDWZESH-ZQINRCPSSA-N Ile-Trp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RWHRUZORDWZESH-ZQINRCPSSA-N 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 1
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 1
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- DUBAVOVZNZKEQQ-AVGNSLFASA-N Leu-Arg-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CCCN=C(N)N DUBAVOVZNZKEQQ-AVGNSLFASA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- NFHJQETXTSDZSI-DCAQKATOSA-N Leu-Cys-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NFHJQETXTSDZSI-DCAQKATOSA-N 0.000 description 1
- HUEBCHPSXSQUGN-GARJFASQSA-N Leu-Cys-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N HUEBCHPSXSQUGN-GARJFASQSA-N 0.000 description 1
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 1
- DPWGZWUMUUJQDT-IUCAKERBSA-N Leu-Gln-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O DPWGZWUMUUJQDT-IUCAKERBSA-N 0.000 description 1
- RSFGIMMPWAXNML-MNXVOIDGSA-N Leu-Gln-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RSFGIMMPWAXNML-MNXVOIDGSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- KVMULWOHPPMHHE-DCAQKATOSA-N Leu-Glu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KVMULWOHPPMHHE-DCAQKATOSA-N 0.000 description 1
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 1
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 1
- IFMPDNRWZZEZSL-SRVKXCTJSA-N Leu-Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O IFMPDNRWZZEZSL-SRVKXCTJSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 1
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 1
- WGCKDDHUFPQSMZ-ZPFDUUQYSA-N Lys-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN WGCKDDHUFPQSMZ-ZPFDUUQYSA-N 0.000 description 1
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- CTJUSALVKAWFFU-CIUDSAMLSA-N Lys-Ser-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N CTJUSALVKAWFFU-CIUDSAMLSA-N 0.000 description 1
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 1
- HLZORBMOISUNIV-DCAQKATOSA-N Met-Ser-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C HLZORBMOISUNIV-DCAQKATOSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 1
- QNZLIVROMORQFH-BQBZGAKWSA-N Pro-Gly-Cys Chemical compound C1C[C@H](NC1)C(=O)NCC(=O)N[C@@H](CS)C(=O)O QNZLIVROMORQFH-BQBZGAKWSA-N 0.000 description 1
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 1
- ZXLUWXWISXIFIX-ACZMJKKPSA-N Ser-Asn-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZXLUWXWISXIFIX-ACZMJKKPSA-N 0.000 description 1
- KMWFXJCGRXBQAC-CIUDSAMLSA-N Ser-Cys-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N KMWFXJCGRXBQAC-CIUDSAMLSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- GVIGVIOEYBOTCB-XIRDDKMYSA-N Ser-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC(C)C)C(O)=O)=CNC2=C1 GVIGVIOEYBOTCB-XIRDDKMYSA-N 0.000 description 1
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 1
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ZUXQFMVPAYGPFJ-JXUBOQSCSA-N Thr-Ala-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN ZUXQFMVPAYGPFJ-JXUBOQSCSA-N 0.000 description 1
- ISLDRLHVPXABBC-IEGACIPQSA-N Thr-Leu-Trp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ISLDRLHVPXABBC-IEGACIPQSA-N 0.000 description 1
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 1
- UIRPULWLRODAEQ-QEJZJMRPSA-N Trp-Ser-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 UIRPULWLRODAEQ-QEJZJMRPSA-N 0.000 description 1
- ZAGPDPNPWYPEIR-SRVKXCTJSA-N Tyr-Cys-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O ZAGPDPNPWYPEIR-SRVKXCTJSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- BMOFUVHDBROBSE-DCAQKATOSA-N Val-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N BMOFUVHDBROBSE-DCAQKATOSA-N 0.000 description 1
- WDIWOIRFNMLNKO-ULQDDVLXSA-N Val-Leu-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WDIWOIRFNMLNKO-ULQDDVLXSA-N 0.000 description 1
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012881 co-culture medium Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention provides an insect-resistant protein hRI, a coding gene and application thereof, and an amino acid sequence of the insect-resistant protein hRI is shown as a sequence 1 in a sequence table. The gene sequence is shown as a sequence 2 in a sequence table. The application of the insect-resistant protein hRI and the gene in improving the insect resistance of plants. The invention applies hRI to plant insect resistance research for the first time, and obtains good insect resistance effect, and the inhibition rate (calculated according to the weight of the insect) of the transgenic insect-resistant plant to the growth of the insect is more than 60%; transgenic insect-resistant plants were very lightly infested as compared to the control.
Description
Technical Field
The invention relates to the technical field of genetic engineering, in particular to an insect-resistant protein hRI, and a coding gene and application thereof.
Background
The insect damage causes the yield and quality loss of crops, seriously affects the stable and sustainable development of agricultural production. The chemical pesticide is used to control insect pest, so that the crop is protected, and serious problems such as pesticide residue, pest resistance evolution, natural enemy killing, environmental pollution and the like are brought. The transgenic insect-resistant crop developed by using the transgenic technology has the characteristics of high efficiency, low cost, environmental protection and the like.
The insect-resistant genes expressed on transgenic insect-resistant plants in agricultural production are mainly delta-endotoxin (Bt toxic protein) from Bacillus thuringiensis, protease/amylase inhibition (e.g. cowpea protease inhibitor CpTI, alpha-amylase inhibitor), plant-mediated RNAi, etc.
In the field of plant insect-resistant genetic engineering, the available insect-resistant gene types in production are very limited at present. The long-term use of the insect-resistant genes inevitably causes the resistance evolution of pests, so that the insect resistance of transgenic plants is reduced or lost, and the agricultural production is re-facing the insect damage threat. With the popularization of the transgenic insect-resistant plants and the extension of the planting period, the problem of pest resistance evolution is more and more prominent, and a new insect-resistant gene or means is required to be sought.
Disclosure of Invention
The invention aims to provide an insect-resistant protein hRI, and a coding gene and application thereof, so as to solve the problems of single excellent insect-resistant gene and insect resistance evolution of the existing transgenic plants, thereby providing a new insect-resistant gene resource for plant insect-resistant genetic engineering.
The invention aims at realizing the following technical scheme: an insect-resistant protein hRI, wherein the amino acid sequence of the insect-resistant protein hRI is shown as a sequence 1 in a sequence table.
The gene for coding the insect-resistant protein hRI has a sequence shown as a sequence 2 in a sequence table.
Recombinant vectors containing the above gene fragments. The recombinant vector is constructed by the following method: the gene fragment shown in the sequence 2 in the sequence table is connected to a pBIN438 plasmid, so as to form a plant expression vector pBIN438-hRI.
The recombinant strain containing the recombinant vector is agrobacterium tumefaciens.
The application of the insect-resistant protein hRI and the gene in improving the insect resistance of plants.
The gene fragment is introduced into a target plant to obtain a transgenic plant, and the insect-resistant protein hRI is expressed in the transgenic plant, so that the insect-resistant property of the transgenic plant is higher than that of the target plant.
The above gene fragment is introduced into a target plant by the above recombinant vector.
The insect resistance means resistance to cotton bollworms.
The target plant is upland cotton or tobacco.
The insect-resistant protein hRI used in the invention is a human ribonucleic acid inhibitor (Human ribonuclease inhibitor, hRI) and is related to degradation inhibition of RNA. hRI binds very strongly to ribonucleases such as RNase1 and bovine RNase A (dissociation constant 3.5X10 -14M-4.5×10-14 M). The invention applies hRI to plant insect resistance research for the first time, and obtains good insect resistance effect, and the inhibition rate (calculated according to the weight of the insect) of the transgenic insect-resistant plant to the growth of the insect is more than 60%; the damage of the transgenic insect-resistant plants was very slight compared to the control.
Degradation enzyme inhibitor genes for plant insect resistance research are reported to be aimed at starch and protein at present; the technology of the invention is based on long-term laboratory verification and analysis, has firm experimental evidence and better application value, can be used as reserve resources of the existing insect-resistant genes, and is used for plant insect-resistant genetic engineering.
Drawings
FIG. 1 inhibitory Activity of recombinant hRI on intestinal RNase Activity in Helicoverpa armigera. (a) hRI protective effect on dsRNA1 (b) protective effect of hRI on dsRNA 2; m: DNA MARKER;1: untreated dsRNA group; 2: dsRNA + hRI untreated group; 3-6: different amounts hRI experimental groups; 7: RRI (commercial recombinant RNA inhibitor, takara, 2313Q) control group; 8: EGFP control group.
FIG. 2pBIN438-hRI vector construction schematic.
FIG. 3 PCR identification of genomic DNA from a hRI transgenic tobacco plant. The number is transgenic plants and WT is wild type plants.
FIG. 4 RT-PCR identification of hRI transgenic tobacco plants. The number is transgenic plants and WT is wild type plants.
Figure 5 24h biting of tobacco leaves. hRI-2, hRI-11, hRI-12 are three tobacco plants expressing hRI and WT is a non-transgenic wild type control.
Fig. 6 feeding rotation hRI tobacco leaf bollworm weight change.
Detailed Description
The technical scheme of the invention is described in detail below with reference to specific embodiments. Test conditions and operations not mentioned in the examples of the present invention are carried out according to conventional methods in the art, and those skilled in the art can refer to related art books, for example: greens, sambrook et al, 4 th edition (2017) of the guidance on molecular cloning experiments, et al.
Example 1
Activity assay of ribonuclease inhibitor hRI protein
The coding gene sequence hRI is obtained by amplifying cDNA of human lung tissue by adopting RT-PCR technology, and the used primer sequence is as follows:
Hrif:5'-CACTCTTCACCTCCACCA-3'
hrir:5'-CTGAGCGTTTCTCTTCAAACC-3'
PCR reactivity procedure: pre-denaturation (95 ℃,3 min), 35 amplifications (95 ℃,10 s;52 ℃, 30s annealing, 72 ℃, 90s extension), and re-extension (72 ℃,10 min). After gel electrophoresis and recovery of target band gel, the target band gel is cloned to pUCm-T vector through enzyme linkage, and the target band gel is verified through transformation, screening and sequencing.
Preparing a prokaryotic expression vector pET17b-TC capable of carrying out TC directional cloning by using a TC cloning method (refer to China patent invention: a TC vector for gene directional cloning and preparation and use methods thereof, patent number CN 201210436709.7); the digested plasmid vector fragment was recovered by XcmI digestion. Primer was used:
HRPepf:5'-ATGAGCCTGGACATCCAGAGCCTGGACATCCAGTGTG-3'
HRPepr:5'-TCAGGAGATGACCCTCAGGGATGGCTTGTCCTTCTCCA-3'
The hRI gene sequence on pUCm-T was amplified and recovered by gel electrophoresis and ligated with the pET-17b-TC large fragment. The hRI gene prokaryotic expression plasmid is obtained after transformation, screening and identification, and then BL21 (DE 3) pLysS escherichia coli competence is introduced.
HRI protein isolation and purification were performed using His-Tag technology: inducing hRI protein expression by IPTG, and checking hRI protein expression products by SDS-PAGE; the induced cells were resuspended in 10mL Tris-HCl lysate (containing lysozyme), allowed to stand at 4℃for 30min to lyse the cells, followed by sonication; the cleaved samples were subjected to imidazole washing and Ni column elution according to HIGH AFFINITY NI-NTA Resin instructions, and finally the resulting purified recombinant hRI protein was checked by SDS-PAGE.
Inhibition assay of the intestinal ribonuclease activity of the recombinant hRI protein in bollworm: taking commercial RNA inhibitor as a control, mixing green fluorescent protein (EGFP) or His-hRI with different amounts of 0.5 mu L of cotton bollworm midgut digestive juice and buffer solution respectively, supplementing 7 mu L with protein eluent, after 30min of 37 ℃ metal bath, respectively adding 60ng dsRNA, quickly mixing, 1h of 37 ℃ metal bath and 5min of 85 ℃ water bath. RNA electrophoresis was performed on 1% agarose gel with DEPC water to examine degradation of dsRNA. The results are shown in FIG. 1.
As shown in fig. 1, under the same experimental conditions, the results of the negative control group (lane 1) show that the buffer used in the experiment has no degradation effect on dsRNA; the dsRNA of the experimental group (lane 8) without hRI is degraded more thoroughly, which reflects that the intestinal enzyme of the cotton bollworm has stronger damage to feeding dsRNA under natural conditions; the dsRNA was partially degraded by addition of the commercial inhibitor RRI (lane 7); in the experimental groups (lanes 3, 4, 5 and 6) with different hRI dosages, the degradation degree of dsRNA is decreased with the increase of hRI dosages (0, 0.25, 0.5 and 1 mu L), and the intestinal enzyme activity of the cotton bollworms is obviously inhibited by the recombinant hRI protein, which shows that hRI has obvious degradation inhibition effect on dsRNA. The results show that hRI of prokaryotic expression has obvious effect in inhibiting degradation of dsRNA by intestinal fluid enzymes.
Example 2
Acquisition of ribonuclease Gene transgenic tobacco
Construction of a plant expression vector: specific primers hripBf and hripSr were designed, wherein hripBf introduced a Kozak sequence and BamH I cleavage site, hripSr introduced a Sal I cleavage site:
hripBf:5'-CGCGGATCCAACAATGGCTAGCCTGGACATCCAGA-3'
hripSr:5'-GCAGGTCGACCCTCAGGAGATGAC-3'
The hRI gene was amplified by PCR using the primer and recovered by gel electrophoresis. The pBIN438-X plasmid and the recovered fragment were double digested respectively with the restriction enzymes BamHI and SalI. The cleavage system (50. Mu.L) was: restriction enzymes 0.8. Mu.L each, corresponding endonuclease Buffer 4. Mu.L, plasmid 34.3. Mu.L to be digested, overnight digestion at 37℃were used, and the vector backbone and target fragment were recovered by electrophoresis, and the concentration of the recovered product was estimated. And (3) carrying out enzyme ligation, transformation and screening identification according to the proportion of the carrier fragment to the target fragment of 1:3-1:10. The PCR identification primer is hripBf/Sr, and restriction enzymes used for enzyme digestion identification are EcoR I and Hind III. The structure of the plant expression vector pBIN438X-hRI is shown in FIG. 2.
Acquisition of sterile seedlings and genetic transformation: selecting full wild tobacco seeds, removing impurities, sequentially sterilizing with alcohol and NaClO solution, and uniformly planting in MS solid culture medium (Murashige and Skoog solid culture medium); culturing in a plant growth box under the following conditions: the temperature is 28+/-1 ℃, the relative humidity is 65+/-5%, and the photoperiod is 16L:8D. Under aseptic conditions, suitably sized tobacco seedlings were transferred to tissue culture flasks containing MS solid medium. When the height of the aseptic seedling reaches about 10cm, taking the leaves for agrobacterium-mediated leaf disk transformation. The method comprises the following steps: (1) leaf preculture: cutting sterile wild tobacco leaves with good growth vigor into cubes (the size is about 1cm multiplied by 1 cm), uniformly spreading the leaves on MS solid culture medium containing antibiotic-free according to the back surface direction by forceps, and culturing in a climatic chamber for 2d; (2) agrobacterium expansion culture: the agrobacterium containing the recombinant plasmid pBIN438X-hRI is taken from an ultralow temperature refrigerator at the temperature of minus 80 ℃ and is transferred into 150mL LB liquid culture medium for expansion culture after being activated for 24 hours at the temperature of 28 ℃ at 220rpm/min, and the culture is carried out until the logarithmic phase; (3) bacterial liquid concentration: centrifuging the cell in the growth period of the mobile phone at 4 ℃ and 4000rpm, washing the cell for 2 times by using an MS liquid culture medium, and then re-suspending the cell in 100mL of the MS liquid culture medium; (4) infestation: lightly clamping the precultured leaf into MS liquid heavy suspension, vibrating and infecting for 15min, placing the leaf on sterilized filter paper, sucking redundant liquid, clamping the back of the leaf downwards, placing the leaf into a flat plate containing co-culture medium, wrapping the flat plate with newspaper, and culturing for 2d in a dark state; (5) cleaning and selecting culture of the leaves; firstly, cleaning the leaves for 3 times by using sterile ddH 2 O, finally cleaning the leaves for 1 time by using an MS liquid culture medium, and placing the back surfaces of the leaves on a selective differentiation culture medium downwards for selective culture; (6) continuing to culture: cutting off the differentiated buds, inserting the buds into a tissue culture bottle for rooting culture, and finally, when transgenic tobacco grows to about 10cm, slightly taking out regenerated plants from the tissue culture bottle by using long tweezers, flushing roots by flowing cold water, removing residual tissue culture medium and transferring the roots into soil.
Molecular identification of transgenic tobacco: extracting DNA of tobacco leaves by using a CTAB method, amplifying the DNA by using a specific identification primer, detecting whether hRI is integrated into tobacco genome, and using a primer sequence:
RNH1igF:5'-CAGCAGTGCCAAGTGGTCAG-3'
RNH1igR:5-'CAATGCCGCACAGGTCCC-3'
Identification of transcript levels: total RNA from fresh leaves of tobacco was extracted with TRIzol reagent and reverse transcribed, and wild-type tobacco total RNA was used as a control. RT-PCR amplification is performed by using the primers, and whether the target gene is transcribed or not is identified. In the identification process, the method is at least extracted twice independently, and PCR or RT-PCR identification is carried out twice each time to ensure the accuracy of the result. Genomic and transcriptional levels were identified for transgenic plants (FIG. 3) and (FIG. 4).
Example 3
Insect resistance analysis of transgenic tobacco
Cutting artificial feed into small pieces of about 0.5cm×0.5cm, placing in sterile culture dish, inoculating larva of cotton bollworm egg to feed, and standing to 2 years (body length 0.42cm-0.62 cm) for insect test analysis. Selecting 3T 1 generation single copy transgenic lines, wherein each plant selects 3 tobacco leaves with consistent growth vigor to feed cotton bollworms, and simultaneously selects leaves with consistent growth vigor in wild tobacco planted in the same period to feed cotton bollworms as a control. 3 single copy tobacco plants of the same gene are set as repeat groups to reduce errors caused by different gene insertion sites; 3 leaves of the same tobacco are set as repeated tests in a group, so that human errors caused by selecting the leaves are reduced; the bollworm weights in each group were weighed 3 times to reduce occasional errors in weight measurement, and the average value was taken during subsequent data processing. Selecting 16 cotton bollworm larvae with the same growth vigor and the same weight from cotton bollworms in the 2 nd age, and placing the cotton bollworms larvae into a locker box with leaves. The body weight of the cotton bollworms is weighed every 24 hours, the residual quantity of the cotton bollworms is counted, and the data is counted to 120 hours. The status of blade bite at 24h was observed and recorded for photographing. During the insect test, the lockers were cleaned every 24 hours and fresh tobacco leaves were replaced. And finally, calculating the average weight of the cotton bollworms according to the statistical data, and comparing the differences among the average weights of the cotton bollworms among different groups by using IBM SPSS STATISTICS software through single-factor analysis of variance. An average cotton bollworm weight line graph was drawn with Excel 2016 software based on the results of the statistical analysis.
The biting condition of 24h tobacco leaves was recorded by photographing, and the result is shown in the graph (fig. 5). The results show that the experimental group (hRI) and the control group (wild WT) are subjected to different degrees of bite damage after being fed with the second-instar larvae of cotton bollworms for 24 hours, wherein the bite situation of wild tobacco leaves is serious, and the bite situation of hRI tobacco leaves is light. It can be seen that the insect resistance of the transgenic hRI gene tobacco is obviously improved.
Average body weight gain of cotton bollworms (table 1) and a line graph of average body weight gain of cotton bollworms (fig. 6) were plotted for five time periods of feeding wild type tobacco and transgenic hRI tobacco for 24h, 48h, 72h, 96h, 120 h.
Table 1: average body weight (g) of cotton bollworms at different time periods of feeding rotation hRI leaves
Note that: different lowercase letters in the same column indicate significant differences at the level P < 0.05; the different capital letters in the same column indicate that the difference is very significant at the level P < 0.01.
The trend of weight gain showed that: in the same time period, the feeding rotation hRI tobacco group is obviously lower than the feeding wild type tobacco group, the feeding rotation hRI tobacco group is obviously different from the feeding wild type tobacco group in 48 hours, the starting difference of 72 hours reaches an extremely obvious level, and the result shows that the rotation hRI tobacco bollworm larva has obvious inhibition effect. There was no significant difference between the average weights of the 3 groups of cotton bollworms feeding the hRI tobacco, indicating that the insect inhibitory ability of the hRI tobacco in the insect test analysis was not affected by the gene insertion site.
Sequence listing
<110> University of Hebei
<120> Insect-resistant protein hRI, and coding gene and application thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 461
<212> PRT
<213> Person (Human)
<400> 1
Met Ser Leu Asp Ile Gln Ser Leu Asp Ile Gln Cys Glu Glu Leu Ser
1 5 10 15
Asp Ala Arg Trp Ala Glu Leu Leu Pro Leu Leu Gln Gln Cys Gln Val
20 25 30
Val Arg Leu Asp Asp Cys Gly Leu Thr Glu Ala Arg Cys Lys Asp Ile
35 40 45
Ser Ser Ala Leu Arg Val Asn Pro Ala Leu Ala Glu Leu Asn Leu Arg
50 55 60
Ser Asn Glu Leu Gly Asp Val Gly Val His Cys Val Leu Gln Gly Leu
65 70 75 80
Gln Thr Pro Ser Cys Lys Ile Gln Lys Leu Ser Leu Gln Asn Cys Cys
85 90 95
Leu Thr Gly Ala Gly Cys Gly Val Leu Ser Ser Thr Leu Arg Thr Leu
100 105 110
Pro Thr Leu Gln Glu Leu His Leu Ser Asp Asn Leu Leu Gly Asp Ala
115 120 125
Gly Leu Gln Leu Leu Cys Glu Gly Leu Leu Asp Pro Gln Cys Arg Leu
130 135 140
Glu Lys Leu Gln Leu Glu Tyr Cys Ser Leu Ser Ala Ala Ser Cys Glu
145 150 155 160
Pro Leu Ala Ser Val Leu Arg Ala Lys Pro Asp Phe Lys Glu Leu Thr
165 170 175
Val Ser Asn Asn Asp Ile Asn Glu Ala Gly Val Arg Val Leu Cys Gln
180 185 190
Gly Leu Lys Asp Ser Pro Cys Gln Leu Glu Ala Leu Lys Leu Glu Ser
195 200 205
Cys Gly Val Thr Ser Asp Asn Cys Arg Asp Leu Cys Gly Ile Val Ala
210 215 220
Ser Lys Ala Ser Leu Arg Glu Leu Ala Leu Gly Ser Asn Lys Leu Gly
225 230 235 240
Asp Val Gly Met Ala Glu Leu Cys Pro Gly Leu Leu His Pro Ser Ser
245 250 255
Arg Leu Arg Thr Leu Trp Ile Trp Glu Cys Gly Ile Thr Ala Lys Gly
260 265 270
Cys Gly Asp Leu Cys Arg Val Leu Arg Ala Lys Glu Ser Leu Lys Glu
275 280 285
Leu Ser Leu Ala Gly Asn Glu Leu Gly Asp Glu Gly Ala Arg Leu Leu
290 295 300
Cys Glu Thr Leu Leu Glu Pro Gly Cys Gln Leu Glu Ser Leu Trp Val
305 310 315 320
Lys Ser Cys Ser Phe Thr Ala Ala Cys Cys Ser His Phe Ser Ser Val
325 330 335
Leu Ala Gln Asn Arg Phe Leu Leu Glu Leu Gln Ile Ser Asn Asn Arg
340 345 350
Leu Glu Asp Ala Gly Val Arg Glu Leu Cys Gln Gly Leu Gly Gln Pro
355 360 365
Gly Ser Val Leu Arg Val Leu Trp Leu Ala Asp Cys Asp Val Ser Asp
370 375 380
Ser Ser Cys Ser Ser Leu Ala Ala Thr Leu Leu Ala Asn His Ser Leu
385 390 395 400
Arg Glu Leu Asp Leu Ser Asn Asn Cys Leu Gly Asp Ala Gly Ile Leu
405 410 415
Gln Leu Val Glu Ser Val Arg Gln Pro Gly Cys Leu Leu Glu Gln Leu
420 425 430
Val Leu Tyr Asp Ile Tyr Trp Ser Glu Glu Met Glu Asp Arg Leu Gln
435 440 445
Ala Leu Glu Lys Asp Lys Pro Ser Leu Arg Val Ile Ser
450 455 460
<210> 2
<211> 1386
<212> DNA
<213> Person (Human)
<400> 2
atgagcctgg acatccagag cctggacatc cagtgtgagg agctgagcga cgctagatgg 60
gccgagctcc tccctctgct ccagcagtgc caagtggtca ggctggacga ctgtggcctc 120
acggaagcac ggtgcaagga catcagctct gcacttcgag tcaaccctgc actggcagag 180
ctcaacctgc gcagcaacga gctgggcgat gtcggcgtgc attgcgtgct ccagggcctg 240
cagaccccct cctgcaagat ccagaagctg agcctccaga actgctgcct gacgggggcc 300
ggctgcgggg tcctgtccag cacactacgc accctgccca ccctgcagga gctgcacctc 360
agcgacaacc tcttggggga tgcgggcctg cagctgctct gcgaaggact cctggacccc 420
cagtgccgcc tggaaaagct gcagctggag tattgcagcc tctcggctgc cagctgcgag 480
cccctggcct ccgtgctcag ggccaagccg gacttcaagg agctcacggt tagcaacaac 540
gacatcaatg aggctggcgt ccgtgtgctg tgccagggcc tgaaggactc cccctgccag 600
ctggaggcgc tcaagctgga gagctgcggt gtgacatcag acaactgccg ggacctgtgc 660
ggcattgtgg cctccaaggc ctcgctgcgg gagctggccc tgggcagcaa caagctgggt 720
gatgtgggca tggcggagct gtgcccaggg ctgctccacc ccagctccag gctcaggacc 780
ctgtggatct gggagtgtgg catcactgcc aagggctgcg gggatctgtg ccgtgtcctc 840
agggccaagg agagcctgaa ggagctcagc ctggccggca acgagctggg ggatgagggt 900
gcccgactgc tgtgtgagac cctgctggaa cctggctgcc agctggagtc gctgtgggtg 960
aagtcctgca gcttcacagc cgcctgctgc tcccacttca gctcagtgct ggcccagaac 1020
aggtttctcc tggagctaca gataagcaac aacaggctgg aggatgcggg cgtgcgggag 1080
ctgtgccagg gcctgggcca gcctggctct gtgctgcggg tgctctggtt ggccgactgc 1140
gatgtgagtg acagcagctg cagcagcctc gccgcaaccc tgttggccaa ccacagcctg 1200
cgtgagctgg acctcagcaa caactgcctg ggggacgccg gcatcctgca gctggtggag 1260
agcgtccggc agccgggctg cctcctggag cagctggtcc tgtacgacat ttactggtct 1320
gaggagatgg aggaccggct gcaggccctg gagaaggaca agccatccct gagggtcatc 1380
tcctga 1386
Claims (4)
1. The application of the insect-resistant protein hRI or the gene thereof in improving the insect resistance of plants; the amino acid sequence of the insect-resistant protein hRI is shown as a sequence 1 in a sequence table, the gene sequence is shown as a sequence 2 in the sequence table, and the insect resistance refers to bollworm resistance.
2. The use according to claim 1, wherein the transgenic plant is obtained by introducing a gene fragment of the insect-resistant protein hRI into the plant of interest, and wherein the insect-resistant protein hRI is expressed in the transgenic plant, such that the insect-resistance of the transgenic plant is higher than that of the plant of interest.
3. The use according to claim 1, wherein the gene fragment of the insect-resistant protein hRI is introduced into the plant of interest by means of a recombinant vector of the gene fragment of the insect-resistant protein hRI; the recombinant vector is constructed by the following method: the gene fragment shown in the sequence 2 in the sequence table is connected to a pBIN438 plasmid, so as to form a plant expression vector pBIN438-hRI.
4. Use according to claim 2 or 3, wherein the plant of interest is upland cotton or tobacco.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111469961.3A CN114316015B (en) | 2021-12-03 | 2021-12-03 | Insect-resistant protein hRI, and encoding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111469961.3A CN114316015B (en) | 2021-12-03 | 2021-12-03 | Insect-resistant protein hRI, and encoding gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114316015A CN114316015A (en) | 2022-04-12 |
CN114316015B true CN114316015B (en) | 2024-06-14 |
Family
ID=81049330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111469961.3A Active CN114316015B (en) | 2021-12-03 | 2021-12-03 | Insect-resistant protein hRI, and encoding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114316015B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1726395A (en) * | 2002-12-17 | 2006-01-25 | 北京诺赛基因组研究中心有限公司 | Specific markers for pancreatic cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6110668A (en) * | 1996-10-07 | 2000-08-29 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Gene synthesis method |
CN107474120B (en) * | 2017-08-16 | 2020-08-18 | 中国农业大学 | Artificially synthesized Bt insecticidal gene mcry1F for transgenic insect-resistant plants |
-
2021
- 2021-12-03 CN CN202111469961.3A patent/CN114316015B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1726395A (en) * | 2002-12-17 | 2006-01-25 | 北京诺赛基因组研究中心有限公司 | Specific markers for pancreatic cancer |
Also Published As
Publication number | Publication date |
---|---|
CN114316015A (en) | 2022-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1941045B1 (en) | Use of a nucleic acid sequence for the generation of a transgenic plant having enhanced drought tolerance | |
CN105802933B (en) | Herbicide tolerance protein, coding gene and application thereof | |
WO2001096584A2 (en) | Materials and methods for the control of nematodes | |
CN109312350B (en) | Abiotic stress tolerant plants and methods | |
EP2635104B1 (en) | Stress-resistant plants and their production | |
CN110819607A (en) | Application of CsLYK gene and coding protein thereof in improving citrus canker resistance | |
CN107674873B (en) | Wheat heat shock transcription factor gene TaHsfA2i, and coding protein and application thereof | |
US20100218278A1 (en) | Method for improved stress tolerance | |
WO2009109123A1 (en) | An artificial synthesized insecticidal gene and the protein encoded by same and uses thereof | |
CN108997487B (en) | Application of stress resistance-related protein Z76 in regulation and control of plant stress resistance | |
CN110713994B (en) | Plant stress tolerance associated protein TaMAPK3, and coding gene and application thereof | |
CN113913457A (en) | Method for inhibiting or killing dichocrocis punctiferalis and application thereof | |
CN107012167A (en) | The expression of the transcription regulaton factor of heat tolerance can be provided | |
CN103172716B (en) | Heat-resistant plant gene and application thereof | |
CN114316015B (en) | Insect-resistant protein hRI, and encoding gene and application thereof | |
CN107663232B (en) | Plant anti-adversity associated protein OsIAA18 and its encoding gene and application | |
CN110564740A (en) | a gene AtPIP2 for improving disease resistance of plants; 7 and uses thereof | |
Wang et al. | Functional analysis of a wheat pleiotropic drug resistance gene involved in Fusarium head blight resistance | |
CN110669761B (en) | Nucleotide sequences and methods for controlling insect infestation | |
CN114032245A (en) | Gene VLNHX3D in regulating plant cell Na+And/or K+Application in concentration | |
CN102559703B (en) | Glyphosate-resistant herbicide gene AroA-Ra from grape crown gall antagonistic bacteria rahnella aquatilis and application thereof | |
CN116445499B (en) | DsABCG gene, protein coded by DsABCG gene, recombinant expression vector, method and application | |
CN115011607B (en) | Sesame fertility regulation gene and expression vector and application thereof | |
CN114716521B (en) | Maize drought-resistant related protein and application thereof in plant drought resistance | |
CN110669760B (en) | Nucleotide sequences and methods for controlling insect infestation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |